Can You Take Voltaren (Diclofenac) While Breastfeeding?

Lauren Okafor | MD

Medically reviewed by Lauren Okafor | MD , The Frank H Netter MD School of Medicine, Loyola University Medical Center on June 25th, 2026. Updated on June 25th, 2026

Key Takeaways

  • Topical diclofenac generally poses lower risk than oral forms due to minimal systemic absorption

  • Short-term, targeted use is typically considered acceptable with medical supervision

  • Timing doses after breastfeeding sessions can minimize infant exposure

  • Alternative pain relief options may be preferable for long-term use

  • Individual medical consultation is essential for personalized safety assessment

Understanding Diclofenac Safety During Breastfeeding

Diclofenac, commonly known by the brand name Voltaren, is a nonsteroidal anti-inflammatory drug (NSAID) frequently prescribed for pain and inflammation. For breastfeeding mothers dealing with postpartum discomfort, arthritis, or injury-related pain, understanding the safety profile of this medication is crucial for making informed decisions.

The American Academy of Pediatrics considers diclofenac usually compatible with breastfeeding, though caution is recommended. Studies show that diclofenac passes into breast milk in relatively small amounts, with breast milk concentrations typically measuring less than 1% of the maternal dose. This low transfer rate, combined with the medication's short half-life, makes it a possible option for nursing mothers when used appropriately.

Similar to concerns about taking ibuprofen while breastfeeding, the key lies in understanding proper usage and timing. Doctronic's AI consultations, which maintain 99.2% treatment plan alignment with board-certified physicians, can help assess individual circumstances and provide personalized guidance for medication safety during breastfeeding.

Comparing Oral and Topical Formulations

The route of administration significantly impacts the safety profile of diclofenac for nursing mothers. Oral diclofenac tablets result in higher systemic absorption, leading to increased concentrations in breast milk compared to topical applications.

Topical Voltaren gel offers several advantages for breastfeeding women. When applied to the skin, only 1-5% of the medication is absorbed systemically, dramatically reducing the amount that reaches breast milk. This localized approach allows for targeted pain relief while minimizing infant exposure.

Clinical studies demonstrate that breast milk concentrations following topical diclofenac use are often below detectable limits. The medication achieves therapeutic levels at the application site without significant systemic circulation, making it a preferred choice for nursing mothers requiring localized pain management.

Formulation

Systemic Absorption

Breast Milk Transfer

Safety Rating

Recommended Use

Oral Diclofenac

50-60%

Low to Moderate

Use with caution

Short-term, after feeding

Voltaren Gel

1-5%

Minimal

Preferred option

As needed for localized pain

Ibuprofen

80-90%

Very low

First-line choice

Standard dosing acceptable

Optimal Timing and Dosage Strategies

Timing medication administration around breastfeeding sessions can help minimize infant exposure to diclofenac. For oral formulations, taking the medication immediately after nursing provides the longest interval before the next feeding session, allowing drug levels in breast milk to decrease.

The lowest effective dose should always be the goal when using any medication while breastfeeding. Many healthcare providers recommend starting with topical formulations before considering oral options. This approach aligns with the principle of minimizing systemic exposure while achieving adequate pain relief.

Short-term use is generally preferable to long-term treatment regimens. If chronic pain management is necessary, discussing alternative approaches with healthcare providers becomes essential. Just as with other medications, the duration and frequency of use play crucial roles in determining overall safety.

Monitoring Your Baby for Potential Effects

While serious adverse effects in breastfed infants are rare with diclofenac use, parents should remain vigilant for potential signs of medication exposure. Digestive symptoms such as unusual fussiness, changes in feeding patterns, or gastrointestinal upset may indicate infant sensitivity to the medication.

Neurological effects, though uncommon, could manifest as increased drowsiness, irritability, or changes in sleep patterns. Skin reactions, including rash or unusual sensitivity, should prompt immediate consultation with a pediatric healthcare provider.

Premature infants and newborns under four weeks old may be at higher risk for medication effects due to their immature metabolic systems. Close monitoring becomes particularly important for these vulnerable populations, and healthcare providers may recommend alternative pain management strategies.

Safer Alternatives for Nursing Mothers

Several pain relief options offer better safety profiles for breastfeeding mothers. Acetaminophen remains the first-line choice for many healthcare providers due to its excellent safety record and minimal breast milk transfer. The medication effectively manages mild to moderate pain with virtually no risk to nursing infants.

Ibuprofen represents another well-studied alternative with extensive safety data in breastfeeding populations. Its anti-inflammatory properties make it particularly useful for conditions involving swelling or inflammation, similar to diclofenac's therapeutic effects.

Non-pharmaceutical approaches deserve consideration as part of a comprehensive pain management strategy. Physical therapy, heat and cold application, gentle exercise, and relaxation techniques can complement or sometimes replace medication use. These methods carry no risk of infant exposure while supporting overall maternal wellness.

Making Informed Treatment Decisions

The decision to use diclofenac while breastfeeding should involve careful consideration of individual circumstances. Factors such as the severity of pain, availability of alternatives, infant age and health status, and frequency of nursing all influence the risk-benefit analysis.

Healthcare providers can offer personalized guidance based on your specific situation. With Doctronic's comprehensive healthcare support, mothers can access reliable information and guidance 24/7, helping navigate medication safety questions with confidence and peace of mind. The goal remains achieving effective treatment while prioritizing infant safety through open communication with healthcare providers and careful monitoring of both maternal symptoms and infant well-being.

Frequently Asked Questions

With oral diclofenac, waiting 2-3 hours after taking the medication may reduce infant exposure. However, the drug can remain in your system for 12-15 hours. Topical forms have minimal waiting requirements due to low systemic absorption rates and minimal breast milk transfer rates.

Yes, topical Voltaren gel is generally considered safer because only 1-5% is absorbed systemically, resulting in much lower breast milk concentrations compared to oral diclofenac tablets that achieve 50-60% systemic absorption and greater infant exposure risk.

Potential infant side effects are rare but may include digestive upset, drowsiness, or skin rash. Monitor your baby for unusual symptoms and contact your healthcare provider immediately if concerns arise during breastfeeding or after medication use.

Ibuprofen and acetaminophen are typically considered first-line choices for nursing mothers. These medications have extensive safety data and minimal transfer to breast milk when used at recommended dosages for pain management.

Pumping and dumping is generally not necessary with topical Voltaren gel due to its minimal systemic absorption and negligible breast milk transfer. Consult your healthcare provider for personalized guidance based on your specific medical situation.

The Bottom Line

Diclofenac can be used cautiously during breastfeeding, with topical formulations like Voltaren gel generally being preferred over oral forms due to lower systemic absorption and minimal breast milk transfer. The medication's transfer to breast milk is considered low to moderate, and short-term use with proper timing may minimize infant exposure. Individual factors such as your baby's age, health status, and feeding patterns should influence treatment decisions. Alternative pain management options may be more suitable for long-term use. This information is educational in nature and should not replace professional medical advice. Confirm with a licensed clinician for new, worsening, or high-risk symptoms.

Related Articles

Get women's health advice